Comparison of 2‐year clinical outcomes between zotarolimus‐, sirolimus‐, and paclitaxel‐eluting stents in real life clinical practice

Publisher： John Wiley & Sons Inc

E-ISSN： 1522-726x|83|3|349-359

ISSN： 1522-1946

Source： CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol.83, Iss.3, 2014-02, pp. : 349-359

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of 5‐year outcomes of paclitaxel‐eluting and endeavor zotarolimus‐eluting stents in New York

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 91, Iss. 1, 2018-01 ,pp. : 9-16

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of 2‐year outcomes between zotarolimus‐eluting and everolimus‐eluting new‐generation cobalt–chromium alloy stents in real‐world diabetic patients

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 86, Iss. 1, 2015-07 ,pp. : E11-E18

John Wiley & Sons Inc

Access to resources Recommend Favorite

Five‐year clinical follow‐up of a randomized comparison of a polymer‐free sirolimus‐eluting stent versus a polymer‐based paclitaxel‐eluting stent in patients with diabetes mellitus (LIPSIA Yukon trial)

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 83, Iss. 3, 2014-02 ,pp. : 418-424

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents in patients with coronary artery disease

By Zhang Feng   Dong Lili   Qian Juying   Ge Junbo  

Annals of Medicine, Vol. 43, Iss. 1, 2011-02 ,pp. : 75-79

Informa Healthcare

Access to resources Recommend Favorite

Comparison of Bare-Metal and Sirolimus- or Paclitaxel-Eluting Stents for Aorto-Ostial Coronary Disease

By  

Cardiology, Vol. 111, Iss. 4, 2008-05 ,pp. : 270-276

Karger

Access to resources Recommend Favorite